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ptS.W4thAE (%) 10(12) 19 (21.3)
AE 13 24
pta. withheadache (%) 8 (9.6)* 19(21.3)
drop-out(%) 5 (6) 6 (5.6)
EFFICACY reSUlt9
Ischemicthresh. llme (sec.) HR X BP prod.
A B A B
Basal 7.66 7.14 21812 22136
2 weeks 8,86? 8.Z5t 23789t 2322.7t
4 weeka 9.58? 9.lot 24030t 242s4t
6 weeks 9.9ot 9.46t 24569t 24564t
(*p <0.05 AvS B-CHI SQ.; tp < 0.05 vsbasal-ANOVA)
Cono/Uslorr: MC showeda goodsafetyprofile;the incidenceof AEand
particuladyof headachewassignificantlyloweringroupA.
No arrhythmiaswere obsewedand otherAEs occurredin a very low









motility by 11.2%at 42 days. Sinoeconoemsexist on eaferyof early
vasodilationafterMl,weusedtheGISSI-3databaee(19318pta)todescribe
(a)dosesof L usedin the200parficlpatlngCCU(75%of itelianCCU),and
(b)clinicaldeterminantsofLdosesinthefiret4daysandatdischarge.Target
daily L doseby protooolwee5 mgfor days1 and 2, then 10 mg upto 42
days;ptawithsystolicbloodpressure(SSP)s 120mmHgondays1 thru3
couldbe given2.5 rng.MeanL dose(mg)wason day 14.2 + 16(mean+
SD),day2 4.6+ 2.2,day36.3 + 3.5,day46.6 + 3.7,discharge(14days)
7.2 + 4.2.Variablealikelyto influenceL prescribeddosewereintroducedin
a multivariatelogisticmodelandyieidadthefollowingresults:(a)significant
determinantofuseof targetLdoeeondays1tfiru4 (?5 m@day)weshietory
of hypertension(OR1.44,95°76Cl, 1.28-1.80),whileptewithSBPat entry
of 10&120 mmHg(OR0.44,95%Cl 0.40-0.47),andpteaged>70 y (OR
0.85, 95% Ci 0.78-0.95) receivedlowerdoses;(b) determinantof useof
targetL doseat diacharge(210 mglday)was historyof hypertension(OR













Severalreoentstudieshave demonstratedthat, similarto acute Ml and
suddendeath, episodesof myocerdialischemiaalso havea diurnalpet-
tem withan increasedfrequencyanddurationin the morning(8 am-noon)
hours.Baeadon thesedata, it has beensuggestedthat administrationof
antiischemicdrugs beforebedtimemight be of greaterbenefit in raduc-
ing the risk of ischemiain the morning.Accordingly,in this double-biind,
placebo-ocmtrolled,multioanterstudy,we evaiuatedthe effioaoyof onoe-a-
day formulationof diltiazem,D (dilacorXR, Rhone-PouiencRorer)given
eitheras4S0mgdosebetween7% am or betweenS-10 pmin a random-
ized,crossovermanner.Forty-eight-hourambulatoryECGmonitoring(AEM)
wasperformedat baselineand at the end of eachstudyphaea.A total of
88 ptewith establishedCAD,stabieangina,andambulatoryiechemia(22
mink%h) oompletedall phasesof thestudy.At baselineprforto AMdosing
therewasanaverageof 2.1 + 3.2 ischemicepisodes(lEs)accountingfora
meandurationof 49 + 6Srein,andAMdosingwithD significantlyreduoed
theseto 0.9+ 1.4IEsand22+47 rein,respeorively(p < 0.002).Priorto the
PMdosingtheaverageIEswere1.5+ 1.4witha meandurationof 36 + 57
minandthe PMdosingwithD significantlyreducedtheseto 0.8 & 1.4IEs
and20A 42rein,respectively(p < 0.02).overall,D reduoadIEsby45%and
ischemicdurationby40%duringthemonitoringperiod.Compariarrnof AEM
datarevealedthatbothAMand PMdosingwith Dwereequallyeffectivein
reducingthe riskof ischemiain the morninghours,Theseresuksindicate










levelsof ET-1havabeensuggestedto beof importanceinthepathogenesis
of myocerdialischemia.Aimof the presentstudywasto evaluatethe effaot











Anerial 1.48 i 0.2 1.52A0.1
Comnary.sinus 1,53* 0.4 1.56+ 0.3
BseslinePacing
Coronarysinus 2.31 + 0.2 2,33 & 0.4
“hA-CSChange 44,6 ”/0 46,1%
Pacingsfter studydrug
Coronarysinus 2.07 & 0.3 2.32 + 0.4
O/.A-Cc Change 32.7% 45.9%*
Drugvs Basaiins Pacing –11.9”/0 –0.2%”
Values in ngrl;*p <0.01 E vs P; A = Arterial;Cs = Coronary sinue
In conclusion E reduces the ischamia-induoed oardiac release of ET-1.
Thia may contribute to the cardioprotactive effects of the horrnona.
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CardiactroponinI (cTni)has been shownto be a highiyapaoificmarker
of myocerdialiachemiaallowingdetectionof minormyooardialinjuryunde-
tectableby CK-MBmeasurement.We prospectivelystudied60 Pta(64 +




upperlimit of normal= 0.6 j@) and was aaaessed6, 12, 24, 48 end 72
h afteradmission.All Pfshada coronaryangiogramduringhospitalization
withquantitativeangiographicanalysisof theculpritlesionto aeaeesminimal
iumendiameter(MLD),% diameterstenosie(YoDS)and referenoediameter
(RD).Clinioalfaatures,T or STchanges,recurrenceof pain,MLD,RDand
% DSand needfor revascularisationwerecomparedin Ptswithor without
cTnlelevation.
J A C CFebruary 1997 ABSTRACTS - Oral 211A
Resu/fs:Among80 Pts,31 (39Yo) hada cTnl z 0.6 I@l (mean:2,51*
1.96I.@). ThesePtshada longerdurationof pain(31A 16vs 10• 8 rein,
p < 0.0001),morefrequentECGabnormalitiesat admission(81VS41%,
p -=0.003)and a moresevereculpritlesion(MLD:o.go+ o.% vs 1.17+
0.49mmp <0.05, % DS: 72 + 9 vs 62 + 13%, p < 0.007). Nodifference
wasobservedfor chestpain recurrences,ejectionfraction,RD,numberof
diseasedvessels.Urgentrevascularisatlonwas raqukadIn 19 Pts (61%)
with increasedcTnl (8 CABG,11PTCA)and In 16 Pts(33%)withno cTnl
increase(5CABG,11PTCA)(p < 0.01).
Conckdorr:increaseIn cTnl despiteno changesin CK-MBoccurredin
38%of Ptswithunstableangina.ThesePtshadmoresevereclinical,ECG
and angiographicfeaturesthat led to morefrequentneedfor revaacUlari-










over=12 hoursfor riskstratification.ToevaluatetroponinT (TnT)as a risk
markerInCPUpatients,wemmparsdevaluationbyTnTdrawnat0,4, and8
hourawitha standard12-hourprotocolofq4 hourECGandCK-MBanalysie
in 208 consecutivepatientsassignedto our CPUovera 4-monthperiod.
Diagnosticwork-upwasleftto theatfendingcardiologist.
25 patients(12.0%)were TnT (+) (?0.1 n~ml); 1 patient(0.5%)was
CK-MB(+)(>9 rig/ml).NoTnT(-) (< 0.1n~ml) patientswerelaterCK-MB
(+).68 patientshadnofurtherwork-updueto low-riskatypicalfeatures,iife-




TnT(+)(n=18) TnT(-) (n=124) pvalu?
Cm bvearh S/lo(80%) ler40(3s%) 0.010







m7563 Early Emergency Department Echocardiography is aSeneitive and Independent Predictor of Adveree




accuratelyidentifymyocardialinfarction(Ml) in patients(pts) presenting
to the EmergencyDepatiment(ED)with chest pain. However,its ability




werefocalwall motionabnormalities(hype-or akinesis)in two contiguous
segmentsorthe ejectionfractionwas<40%.ECGSwereconsideredpoaitive
for ischemiaif therewas?1 mmST-segmentelevationor depression.End
pointsconsideredasadveraecardiacoutcomeswereMlorrevaacularization
(PTCAor CVG).Results:Of the 260pts,55 hadadverseoutcomes(23Ml,
19PTCA,3CVG).Sensitivityof ECHOforpredictingadverseoutcomeswas
higherthantheECG(89Y0vs39%,p < 0.0001),thoughspecificitywaslower
(75%vs94%,p < 0.001).Whenaddedto thebaselineclinicalvariablesand
theECG,chi-squaraincreasedfrom23.5t043.5(p< 0.13301),demonstrating
significantincrementalvalue.Ina multi-variateanalyais,onlymalesex(p <
0.03, relativerisk [RR]2.4) and an abnormalECHO(p <0.0001, RR24)
predictedan adverseoutcome.In ptswithnondiagnosticECGS,sensitivity
of ECHO(82%)was not significantlychanged,and an abnormalECHO
wastheoniymultivariatepredictorof an adverseoutcome(p <0.0001, RR
14.4).Conclusions:EarlyECHOperformedin the ED identifiespteat risk









dinal determinantof survival.Earlyassessmentof LV functionmay allow
definitionof subjectsrequiringintervention.Conversely,identificationof nor-
malLVfunctioninpatientspresentingwithchestpainmayaidtheprocessof
CCUtriage.We havemeasuredLVfunctionat the bedsidein 378 patianta
afterAMI by Dopplermeasurementof Strokedistance(So - the systolic
velocityintegralof blood-flowin the eorticarch.Survivaldatefor a mean5
(range2-7) yearfollow-upperiotiaregiven.
Mean(S Dev)Sdwas 81 (19)%of the age-predictednormalvalue.For
patientswithSd> 100%(n.60), 82-100%(n= 134),63-81%(n= 122),and
43% (n = 62),the 1 yearmortalityrates(95%Cl) were3% (0-12%),7%
(2-11%),10%(5-15%),and29%(16-40%),respectively;thecorresponding
estimatesfor mortalityup to 5 yearswere17, 19,24, and 56%.Fiveyear
survivalwas significantlyworse(P < 0.01) in thosewith Sd of leesthan
the mean(81%).Theareasunderthe receiveroperatoroharacterfsticplots
were 81, 76, 71, and 65%for deathswithin 1 month,6 months,1 year,
and2 years.Thus,the predictivepowerof the measurementwasstrongest
sea! afterAMI,witha valueof 81%predictingdeathwithin1 monthwitha
sensitivityof89Y0anda apecificltyof53%;for Sd< 630A,thesefigureswere
61%and86%,raapactlvely.
Measurementof Sdoffersthe prospectof a ubiquitousmeansof earty,




756-5 The Effecthreneee of A Chest Pain Obeervatlon Unit
‘ (CPU) in Emergency Triage of Patients at
Intermediate Risk for Coronary Events: The CHEER




Obpctive:To evaluatethe safety,outcomesand cost-effectivenessof an
ERbasedCPUin thetriageof patientswith interrnediatariskfor short-term
cardiaceventa.Priorreportshavefocusedonlowriskpatients,however,the
majorityof patientswith unstableanginaare intermediaterisk.This group
requiresfurtherstudy.
Methods:A communitybaaedcohortpresentingwith chest pain was
classifiedutilizingthe AHCPRunstableanginaguideline.SinceNovember
1995,of 321patientsevaluated,132werehighrisk.Onehundredaeventy-
two intermediateriskpatientswererandomizedto the CPUversusroutine
admission.(Allhighriskpatientswereadmitted.)Patientain the CPUwere
observedfor 6 hourawithcontinuousECGmonitoring,cardiacenzymesat
0,2 and4 hoursand,if appropriate,underwenta treadmillorstressimaging
testafter6 hours.If ailwerenegative,patientsweredismissedto outpatient
foiiow-up.Enrollmentof 542 patients(424 intermediaterisk and.116high
risk)willbecompletedbyDeoember’1996.
Resu/ta:Aa of April 1988,222 patientshavebeen enrolled(69%)and
completedat leastonemonthfollow-up.The primaryoutcomesincludeMl,
cardiovasculardaath,cardiacarrest,CHFor atroke.At the interimanalysis,
thehighriakpatientshada primarycardiovasculareventrateof 18%.Inthe
intermediateriskgroup,the eventratewas7%. Forty-fourpercentof CPU
patientsweredismiasadto homeafterobservation.Comparisonbetweenthe
hospitalizedandCPUgroupawillnotbedoneuntilthe endof theatudy.
Cone/uaion:In this study,the outcomesobservedprospectivelyvalidate
the AHCPRguidelineriakstratification.An ER basedCPUappearato be
a safeandeffectivemeansof managingpatientsat intermediaterisk.Final
resultswillbeavailablein Februry1997.
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n7566 Acute Emergency Department2D Echocardiography
and Tc-9SmTetrofosmht SPECT Imaging in Patients
With Cheat Pain and Nondiagnoetic ECG
S.A.Stowers,J.L.Blackshear,T.H.Abuan,T.J.Szymanaki,
M.E.Schmeider,M.J.Maxwell,F.J.Th.Wackers.% Luke’s/+oapifa/,
Jacksonville,FL,USA,YaleUniversityNewHaven,CT USA
2DechoandTc-99mTetrofosminSPECT(Tc.SPECT)imagingwereevalu-
